FOXC2 and colorectal carcinoma: To elucidate the complex signalling interactions between MRTX1133, METTL14, LINC02159, and FOXC2 in modulating the response of KRASG12D-mutated CRC cells, we established and validated specific cell models (Fig. 9A).